| |
 |
|
Class Information
Number: 424/234.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Bacterium or component thereof or substance produced by said bacterium (e.g., legionella, borrelia, anaplasma, shigella, etc.)
Description: Subject matter involving a bacterium, a component of a bacterium, or a substance produced by a bacterium.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 424/246.1 |
Bacillus |
69 |
| 424/253.1 |
Bordetella (e.g., bordetella bronchiseptica, etc.) |
69 |
| 424/252.1 |
Brucella (e.g., brucella abortus, brucella canis, etc.) |
31 |
| 424/263.1 |
Chlamydia (e.g., chlamydia trachomatis, etc.) |
78 |
| 424/247.1 |
Clostridium (e.g., clostridium tetani, clostridium difficile, clostridium perfringens, clostridium botulinum, clostridium chauvoei, etc.) |
98 |
| 424/245.1 |
Corynebacterium (e.g., corynebacterium diphtheriae, etc.) |
47 |
| 424/257.1 |
Escherichia (e.g., escherichia coli, etc.) |
150 |
| 424/256.1 |
Hemophilus (e.g., hemophilus influenzae, hemophilus gallinarum, hemophilus pleuropnemoniae, etc.) |
196 |
| 424/259.1 |
Klebsiella (e.g., klebsiella pneumoniae, etc.) |
30 |
| 424/251.1 |
Moraxella (e.g., moraxella bovis, etc.) |
55 |
| 424/248.1 |
Mycobacterium (e.g., mycobacterium tuberculosis, calmette-guerin bacillus (i.e., bcg), etc.) |
233 |
| 424/264.1 |
Mycoplasma |
46 |
| 424/249.1 |
Neisseria (e.g., neisseria gonorrhoeae, etc.) |
93 |
| 424/255.1 |
Pasteurella (e.g., pasteurella multocida, pasteurella hemolytica, etc.) |
88 |
| 424/242.1 |
Pilus, fimbria, or adhesin |
81 |
| 424/260.1 |
Pseudomonas (e.g., pseudomonas aeruginosa, etc.) |
90 |
| 424/258.1 |
Salmonella (e.g., salmonella typhimurium, etc.) |
142 |
| 424/243.1 |
Staphylococcus (e.g., staphylococcus aureus, etc.) |
107 |
| 424/244.1 |
Streptococcus (e.g., group b streptococcus, pneumococcus or streptococcus pneumoniae, etc.) |
300 |
| 424/236.1 |
Toxin or toxoid, except endotoxin (e.g., exotoxin, enterotoxin, etc.) |
329 |
| 424/235.1 |
Transposon mutant or deletion mutant bacterium (e.g., produced by transposon mutagenesis, etc.) |
94 |
| 424/262.1 |
Treponema (e.g., treponema hyodysenteriae, treponema pallidum, etc.) |
42 |
| 424/261.1 |
Vibrio (e.g., vibrio cholera, etc.) |
82 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7217791 |
Compositions and methods for treating or preventing pneumococcal infection |
May. 15, 2007 |
| 7217420 |
Mycoplasma gallisepticum formulation |
May. 15, 2007 |
| 7214380 |
Adjuvant therapy |
May. 8, 2007 |
| 7211263 |
Use of adenylate cyclase or bacteria producing it as vaccines against Bordetella |
May. 1, 2007 |
| 7211261 |
Stable liquid formulations of botulinum toxin |
May. 1, 2007 |
| 7208574 |
Host receptor for pathogenic bacteria |
Apr. 24, 2007 |
| 7208166 |
Use of botuline toxin to obtain a product to be used in articular pathologies, particularly coxarthrosis, epicondylitis and rotator muscle cap pathology |
Apr. 24, 2007 |
| 7204993 |
Streptococcus agalactiae vaccine |
Apr. 17, 2007 |
| 7204992 |
P153 and P156 antigens for the immunodiagnosis of canine and human ehrlichioses and uses thereof |
Apr. 17, 2007 |
| 7204991 |
Porphyromonas gingivalis recombinant proteins and truncations |
Apr. 17, 2007 |
| 7201912 |
Recombinant immunogenic compositions and methods for protecting against lethal infections from Bacillus anthracis |
Apr. 10, 2007 |
| 7192725 |
Flagellin gene, flaC of Campylobacter |
Mar. 20, 2007 |
| 7192596 |
Recombinant toxin fragments |
Mar. 20, 2007 |
| 7192588 |
Vaccine composition and method of using the same |
Mar. 20, 2007 |
| 7189405 |
Peptide mimics of conserved gonococcal epitopes and methods and compositions using them |
Mar. 13, 2007 |
| 7189398 |
Broad spectrum pyrogenic exotoxins antagonists and vaccines |
Mar. 13, 2007 |
| 7186411 |
Vaccines absorbable by the transmucosal way |
Mar. 6, 2007 |
| RE39494 |
Inactivated mycoplasma hyopneumoniae and uses therefor |
Feb. 27, 2007 |
| 7179609 |
Screening method for gastritis |
Feb. 20, 2007 |
| 7179448 |
Recombinant constructs of Borrelia burgdorferi |
Feb. 20, 2007 |
| 7172762 |
Erysipelothrix rhusiopathiae antigens and vaccine compositions |
Feb. 6, 2007 |
| 7169394 |
Mycoplasma hyopneumoniae bacterin vaccine |
Jan. 30, 2007 |
| 7169392 |
Neisseria meningitidis serogroup B glycoconjugates and methods of producing the same |
Jan. 30, 2007 |
| 7163810 |
Method for producing target substance |
Jan. 16, 2007 |
| 7163682 |
Glucan binding protein and glucosyltransferase immunogens |
Jan. 16, 2007 |
| 7160549 |
Methods for making compositions including gram negative microbial polypeptides |
Jan. 9, 2007 |
| 7157443 |
Staphylococcus aureus exopolysaccharide and process |
Jan. 2, 2007 |
| 7157089 |
Immune responses using compositions containing stress proteins |
Jan. 2, 2007 |
| 7157088 |
Surface protein of Leptospira |
Jan. 2, 2007 |
| 7153952 |
Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
Dec. 26, 2006 |
| 7153515 |
Method of preventing T cell-mediated responses by the use of the major histocompatibility complex class II analog protein (map protein) from Staphylococcus aureus |
Dec. 26, 2006 |
| 7151171 |
Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
Dec. 19, 2006 |
| 7147857 |
Methods for treating high somatic cell counts |
Dec. 12, 2006 |
| 7144580 |
M. haemolytica outer membrane protein P1pE as a vaccine or vaccine component against shipping fever |
Dec. 5, 2006 |
| 7141244 |
Helicobacter pylori proteins useful for vaccines and diagnostics |
Nov. 28, 2006 |
| 7138125 |
Methods for treating an animal for low milk production |
Nov. 21, 2006 |
| 7138124 |
Polypeptides obtained from gram negative microbes |
Nov. 21, 2006 |
| 7135560 |
Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
Nov. 14, 2006 |
| 7135280 |
Assay to determine efficacy of treatment for mycobacterial infection |
Nov. 14, 2006 |
| 7135188 |
Methods and compositions for immunotherapy of cancer |
Nov. 14, 2006 |
| 7135176 |
VMP-like sequences of pathogenic Borrelia |
Nov. 14, 2006 |
| 7135175 |
Compositions and methods for eliciting an immune response to gram-negative bacterial infections |
Nov. 14, 2006 |
| 7132512 |
Medicament for the treatment of chlamydial infection |
Nov. 7, 2006 |
| 7132107 |
Streptococcus pneumoniae proteins and vaccines |
Nov. 7, 2006 |
| 7132101 |
Compositions and methods for eliciting an immune response to gram-negative bacterial infections |
Nov. 7, 2006 |
| 7129340 |
Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics |
Oct. 31, 2006 |
| 7129339 |
Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
Oct. 31, 2006 |
| 7128910 |
Moraxella catarrahalis outer membrane protein-106 polypeptide, gene sequences and uses thereof |
Oct. 31, 2006 |
| 7125696 |
Method for preparing a polypeptide soluble in an aqueous solvent in the absence of detergent |
Oct. 24, 2006 |
| 7122197 |
Compounds from Moraxella catarrhalis |
Oct. 17, 2006 |
|
|
|
